Ann: MDR expands US digital platform network, page-4

It’s a MedAdvisor tradition to throw out a tickle before the annual AGM to distract from pitchforks being lit. Some years back the share price was 62c (2020), then 38c (2021), now 19c (2022). 7:1 consolidation occurred at 5c in 2019. 52w low was 13c in July.

There might a speculative rise tomorrow. December has always been their best quarter for the year, so it will be interesting to see what “larger than usual” means in the context of revenue. With an uptick in December, it’s March that needs to follow with similar numbers to ensure momentum, give confidence and show continued growth.

With the recent Guildlink acquisition I’d like to see what Big Pharma and Government programs come their way in AU. PlusOne and pharmacy subscriptions is reliable, regular and recurring and its seen saturation has already occurred, hence the jump to NZ. AU/NZ is unlikely to get a “larger than usual” announcement unless there’s other revenue streams.